MENU
MARCH 22, 2024 3:30 PM ET

Supporting Full Workflows for Cell & Gene Therapies

Sponsored by: Thomas Scientific
Speaker
  • Mike Moeller

    Bio: Michael L. Moeller, PhD, has worked in the CGT space for 25 years, including roles as the Chief Scientific Officer of a Biotech startup, as the Scientific Director of the CGT unit of a CRO, and multiple roles in business development at life science companies. He has advanced one of his cellular therapies into 2 Phase I Clinical Trials and is currently focused on becoming a supportive presence for the larger CGT field.

Abstract

Cellular and gene-based therapeutic approaches are the future of medicine for many conditions. As the CGT field expands and deepens, the need for consistent and reliable partners becomes critical. We will review how Thomas Scientific can assist you in your efforts.


You May Also Like
Loading Comments...